Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-003913
Filing Date
2013-01-18
Accepted
2013-01-18 16:27:26
Documents
1
Period of Report
2013-01-17

Document Format Files

Seq Description Document Type Size
1 2013 ANNUAL GRANT rrd366772.html 4  
1 2013 ANNUAL GRANT rrd366772.xml 4 3884
  Complete submission text file 0001181431-13-003913.txt   5246
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 617-503-6500
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TUFTS CNTR FOR THE STUDY OF DRUG DEV 75 KNEELAND ST, SUITE 1100 BOSTON MA 02111
Business Address
KAITIN KENNETH I (Reporting) CIK: 0001271823 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30347 | Film No.: 13537863